secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0000950170-25-108983
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Q2 net loss $4.5M on $4.5M credit loss; Zola revenue up 24%
-------------------------------------------------------------------

- Total revenue $1.455M (+11% YoY); Zola coconut water sales grew 24% to $1.455M.
- Net loss attributable to common $4.458M ($3.26/share) vs net income $1.061M ($0.78/share) in Q2 2024.
- Recorded $4.5M credit loss on Above Food note receivable; received 2.7M shares of ABVE stock.
- Eliminated $1M contingent liability via Bioseed India license termination; total YTD eliminated $2M.
- Gross margins exceeded 30% for tenth consecutive quarter; SG&A fell 21% to $2.123M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017025108983/0000950170-25-108983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017025108983/rkda-20250814.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-108983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer